Medisinsk forskning på cannabis
I dette arkivet finner du over 15 000 lenker til forskningsartikler og studier på cannabis planten. Listen er på engelsk, delt opp i medisinske lidelser og andre kategorier i alfabetisk rekkefølge.
NB! Sidene på hver bokstav kan laste tregt da tusenvis av linker lastes
I
IBS/IBD (86)
-
Small intestinal cannabinoid receptor changes following a single colonic insult with oil of mustard in mice
-
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
-
Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis
-
The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease
-
A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents
-
Pharmacogenetic Trial of a Cannabinoid Agonist Shows Reduced Fasting Colonic Motility in Patients with Non-Constipated Irritable Bowel Syndrome
-
Cannabis use amongst patients with inflammatory bowel disease
-
Cannabinoid receptor 1 gene polymorphism and irritable bowel syndrome in the Korean population: a hypothesis-generating study
-
Role of cannabinoid receptors and RAGE in inflammatory bowel disease
-
Irritable bowel syndrome: a dysfunction of the endocannabinoid system?
-
The Gastrointestinal Pharmacology of Cannabinoids: Focus on Motility
-
Genetic Epidemiology and Pharmacogenetics in Irritable Bowel Syndrome
-
Irritable Bowel Syndrome: Methods, Mechanisms, and Pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome
-
Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea
-
Gut microbiota and the development of obesity
-
The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity
-
Cannabidiol in Inflammatory Bowel Diseases: A Brief Overview
-
The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity
-
Cannabidiol in Inflammatory Bowel Diseases: A Brief Overview
-
Agents that act luminally to treat diarrhoea and constipation
-
Cannabis Finds Its Way into Treatment of Crohnâs Disease
-
Role of endogenous cannabinoid system in the gut
-
Irritable Bowel Syndrome and Migraine: Bystanders or Partners?
-
Endocannabinoid and Cannabinoid-Like Fatty Acid Amide Levels Correlate with Pain Related Symptoms in Patients with IBS-D and IBS-C: A Pilot Study
-
Cannabinoid Receptor 1 Gene and Irritable Bowel Syndrome: Phenotype and Quantitative Traits
-
Inhibition of p38/Mk2 signaling pathway improves the anti-inflammatory effect of WIN55 on mouse experimental colitis
-
Marijuana use patterns among patients with inflammatory bowel disease
-
Endocannabinoid and cannabinoid-like fatty acid amide levels correlate with pain-related symptoms in patients with IBS-D and IBS-C: a pilot study
-
Industrial hemp decreases intestinal motility stronger than indian hemp in mice
-
Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease
-
Preventive and therapeutic oral administration of the pentacyclic triterpene α,β-amyrin ameliorates dextran sulfate sodium-induced colitis in mice: The relevance of cannabinoid system
-
Preventive and therapeutic oral administration of the pentacyclic triterpene α,β-amyrin ameliorates dextran sulfate sodium-induced colitis in mice: The relevance of cannabinoid system
-
Cannabidiol in inflammatory bowel diseases: a brief overview
-
Interleukin 17A evoked mucosal damage is attenuated by cannabidiol and anandamide in a human colonic explant model
-
Inhibition of fatty acid amide hydrolase (FAAH) as a novel therapeutic strategy in the treatment of pain and inflammatory diseases in the gastrointestinal tract
-
Decreased Enteric Fatty Acid Amide Hydrolase Activity is Associated with Colonic Inertia in Slow Transit Constipation
-
Care and Feeding of the Endocannabinoid System: A Systematic Review of Potential Clinical Interventions that Upregulate the Endocannabinoid System
-
Genetic polymorphism in pathogenesis of irritable bowel syndrome
-
Selected terpenoids from medicinal plants modulate endoplasmic reticulum stress in metabolic disorders
-
Palmitoylethanolamide, a naturally-occurring lipid, is an orally effective intestinal antiinflammatory agent
-
Cannabinoids Alleviate Experimentally Induced Intestinal Inflammation by Acting at Central and Peripheral Receptors
-
Endocannabinoid signalling and the deteriorating brain
-
Selective inhibition of FAAH produces antidiarrheal and antinociceptive effect mediated by endocannabinoids and cannabinoid-like fatty acid amides
-
Toward modulation of the endocannabinoid system for treatment of gastrointestinal disease: FAAHster but not âhigherâ
-
Ultramicronized palmitoylethanolamide normalizes intestinal motility in a murine model of post-inflammatory accelerated transit: involvement of CB1 receptors and TRPV1
-
Medical Marijuana for Digestive Disorders: High Time to Prescribe?
-
Antibiotic-induced dysbiosis alters host-bacterial interactions and leads to colonic sensory and motor changes in mice
-
N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon Npalmitoylethanolamine levels and counteracts murine colitis
-
Association of cannabinoid type 1 receptor and fatty acid amide hydrolase genetic polymorphisms in Chinese patients with irritable bowel syndrome
-
Switching cannabinoid response from CB2 agonists to FAAH inhibitors
-
Vagal anandamide signaling via cannabinoid receptor 1 contributes to luminal 5-HT modulation of visceral nociception in rats
-
The endocannabinoid anandamide regulates the peristaltic reflex by reducing neuro-neuronal and neuro-muscular neurotransmission in ascending myenteric reflex pathways in rats
-
Cannabis for inflammatory bowel disease
-
Potential therapeutic applications of cannabinoids in gastrointestinal and liver diseases: Focus on Î9-tetrahydrocannabinol pharmacology
-
Clinical endocannabinoid deficiency (CECD) revisited: Can this concept explain the therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?
-
Identification of a highly potent and selective CB2 agonist, RQ-00202730, for the treatment of irritable bowel syndrome
-
No association between the functional cannabinoid receptor type 2 Q63R variants and inflammatory bowel disease in Turkish subjects
-
Pharmacogenetics in irritable bowel syndrome
-
Monoglyceride lipase-deficiency causes desensitization of intestinal cannabinoid receptor type 1 and increased colonic μ-opioid receptor sensitivity
-
A Gut Microbial Metabolite of Linoleic Acid, 10-Hydroxy-cis-12-octadecenoic Acid, Ameliorates Intestinal Epithelial Barrier Impairment Partially via GPR40-MEK-ERK Pathway
-
AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally-restricted manner
-
In vitro and non-invasive in vivo effects of the cannabinoid-1 receptor agonist AM841 on gastrointestinal motor function in the rat
-
Cannabinoids Regulate Intestinal Motor Function and Electrophysiological Activity of Myocytes in Rodents
-
Cannabis â therapy for the future?
-
Endocannabinoids and the Digestive Tract and Bladder in Health and Disease
-
Patterns of cannabis use in patients with Inflammatory Bowel Disease: A population-based analysis
-
Metabolism of Anandamide by Human Cytochrome P450 2J2 in the Reconstituted System and Human Intestinal Microsomes
-
Endocannabinoids in the Gut
-
The CB2 receptor and its role as a regulator of inflammation
-
Anti-inflammatory effect of cannabinoid agonist WIN55, 212 on mouse experimental colitis is related to inhibition of p38MAPK
-
An Orally Active Cannabis Extract with High Content in Cannabidiol attenuates Chemically-induced Intestinal Inflammation and Hypermotility in the Mouse
-
Therapeutic Use of Cannabis in Inflammatory Bowel Disease
-
The Role of Visceral Hypersensitivity in Irritable Bowel Syndrome: Pharmacological Targets and Novel Treatments
-
Getting into the weed: the role of the endocannabinoid system in the brain-gut axis
-
Medical use of cannabis products : Lessons to be learned from Israel and Canada
-
Efficacy, tolerability, and safety of cannabinoids in gastroenterology : A systematic review
-
RGS proteins as targets in the treatment of intestinal inflammation and visceral pain: New insights and future perspectives
-
The gastrointestinal tract â a central organ of cannabinoid signaling in health and disease
-
Cannabis and Pediatric Inflammatory Bowel Disease: Change Blossoms A Mile High
-
Docosahexaenoyl Serotonin, an endogenously formed n-3 fatty acid-serotonin conjugate has anti-inflammatory properties by attenuating IL-23âIL-17 signalling in macrophages
-
Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review
-
Cannabinoids and GI Disorders: Endogenous and Exogenous
-
Role of cannabis in digestive disorders
-
Dietary Supplement Therapies for Inflammatory Bowel Disease: Crohnâs Disease and Ulcerative Colitis
-
Medical Cannabis â another piece in the mosaic of autoimmunity?
-
Role of cannabis in digestive disorders
IMMUNE SYSTEM (162)
-
Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression
-
Cannabidiol attenuates delayed-type hypersensitivity reactions via suppressing T-cell and macrophage reactivity
-
Do cannabinoids have a therapeutic role in transplantation?
-
Immunoregulation of a CB2 receptor agonist in a murine model of neuroAIDS
-
Cannabinoid receptor activation leads to massive mobilization of myeloid-derived suppressor cells with potent immunosuppressive properties
-
Cannabinoids and Viral Infections
-
Cannabinoids and the immune system: an overview
-
Role of Myeloid-Derived Suppressor Cells in Amelioration of Experimental Autoimmune Hepatitis Following Activation of TRPV1 Receptors by Cannabidiol
-
New blood brothers: the GPR55 and CB2 partnership
-
Commentary: Functional Neuronal CB2 Cannabinoid Receptors in the CNS
-
Cannabinoids and B cells: emerging targets for treating progressive multiple sclerosis
-
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
-
CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura
-
Cannabinoid Receptor 2 Is Critical for the Homing and Retention of Marginal Zone B Lineage Cells and for Efficient T-Independent Immune Responses
-
Deletion of cannabinoid receptors 1 and 2 exacerbates APC function to increase inflammation and cellular immunity during influenza infection
-
Design and evaluation of a novel fluorescent CB2 ligand as probe for receptor visualization in immune cells
-
Modulation of the novel cannabinoid receptor â GPR55 â during rat fetoplacental development
-
Cannabinoids and Innate Immunity: Taking a Toll on Neuroinflammation
-
Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and disease
-
The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells
-
Immunomodulatory properties of kappa opioids and synthetic cannabinoids in HIV-1 neuropathogenesis
-
Cannabis use and Cognitive Function: Eight Year Trajectory in a Young Adult Cohort
-
Cannabinoids and sepsis
-
Dynamic changes to the endocannabinoid system in models of chronic pain
-
Cannabinoid 2 (CB2) Receptor Involvement in the Down-regulation but not Upregulation of Serum IgE Levels in Immunized Mice
-
Tumor necrosis factor activation of vagal afferent terminal calcium is blocked by cannabinoids
-
Cannabinoid Receptor 2 Signaling in Peripheral Immune Cells Modulates Disease Onset and Severity in Mouse Models of Huntingtonâs Disease
-
Mast cell-glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide
-
Endocannabinoid modulation of jejunal afferent responses to LPS
-
Differential migratory properties of monocytes isolated from human subjects naïve and non-naïve to Cannabis
-
The endocannabinoid system: a revolving plate in neuro-immune interaction in health and disease
-
Cannabinoid receptor-2-selective agonists improve recovery in experimental autoimmune encephalomyelitis
-
Involvement of the endogenous cannabinoid 2 ligand 2-arachidonyl glycerol in allergic inflammation
-
Immunity and early pregnancy events: are endocannabinoids the missing link?
-
Î9-tetrahydrocannabinol impairs the inflammatory response to influenza infection: role of antigen-presenting cells and the cannabinoid receptors 1 and 2
-
Magnitude of stimulation dictates the cannabinoid-mediated differential T cell response to HIVgp120
-
Cannabinoid Receptor 2 Protects against Acute Experimental Sepsis in Mice
-
Distinct microRNA expression profile and targeted biological pathways in functional myeloid-derived suppressor cells induced by Î9-Tetrahydrocannabinol in vivo: Regulation of CCAAT/enhancer binding protein alpha by microRNA-690
-
The cannabinoid receptor type 2 as mediator of mesenchymal stromal cell immuno-suppressive properties
-
Cannabinoid Receptor 2 (CB2) Plays a Role in the Generation of Germinal Center and Memory B Cells, but Not in the Production of Antigen-Specific IgG and IgM, in Response to T-dependent Antigens
-
2-Arachidonoyl-glycerol- and arachidonic acid-stimulated neutrophils release anti-microbial effectors against E. coli, S. aureus, HSV-1, and RSV
-
Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell death
-
Effects on Immune Cells of a New 1,8-Naphthyridin-2-One Derivative and Its Analogues as Selective CB2 Agonists: Implications in Multiple Sclerosis
-
Î9-tetrahydrocannabinol impairs the inflammatory response to influenza infection: role of antigen-presenting cells and the cannabinoid receptors 1 and 2
-
Multiple sclerosis and the blood-central nervous system barrier
-
Cannabinoid Receptor 2: Potential Role in Immunomodulation and Neuroinflammation
-
Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors
-
Cannabinoid (CB)1 receptors are critical for the innate immune response to TLR4 stimulation
-
Neuroimmmune interactions of cannabinoids in neurogenesis: focus on interleukin-1β (IL-1β) signalling
-
Cannabinoids Inhibit T-cells via Cannabinoid Receptor 2 in an In Vitro Assay for Graft Rejection, the Mixed Lymphocyte Reaction
-
Cannabinoid receptor modulation of the endothelial cell inflammatory response
-
Cytokine release in sepsis
-
Microarray and Pathway Analysis Reveal Distinct Mechanisms Underlying Cannabinoid Mediated Modulation of LPS-Induced Activation of BV-2 Microglial Cells
-
Targeting the Endocannabinoid System to Treat Sepsis
-
Cannabinoid CB2 receptor gene (CNR2) polymorphism is associated with chronic child-hood immune thrombocytopenia in Egypt
-
Palmitoylethanolamide is a New Possible Pharmacological Treatment for the Inflammation Associated with Trauma
-
Inhibition of the cannabinoid 2 receptor in CNS-injury induced immunodeficiency syndrome
-
G-protein coupled receptor 18 (GPR18) in channel catfish: expression analysis and efficacy as immunostimulant against Aeromonas hydrophila infection
-
Cannabinoids decrease the th17 inflammatory autoimmune phenotype
-
Therapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists
-
Palmitoylethanolamide stimulates phagocytosis of Escherichia coli K1 by macrophages and increases the resistance of mice against infections
-
Anandamide Attenuates Th-17 Cell-Mediated Delayed-Type Hypersensitivity Response by Triggering IL-10 Production and Consequent microRNA Induction
-
Polyunsaturated Fatty Acid-Derived Lipid Mediators and T Cell Function
-
Experimental cannabinoid 2 receptor-mediated immune modulation in sepsis
-
The in vitro GcMAF effects on endocannabinoid system transcriptionomics, receptor formation, and cell activity of autism-derived macrophages
-
The expression of cannabinoid receptor 1 is significantly increased in atopic patients
-
Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis
-
A cannabigerol derivative suppresses immune responses and protects mice from experimental autoimmune encephalomyelitis
-
Antagonism of cannabinoid receptor 2 pathway suppresses IL-6-induced immunoglobulin IgM secretion
-
Characterization of endocannabinoid-mediated induction of myeloid-derived suppressor cells involving mast cells and MCP-1
-
Cannabinoid inhibits HIV-1 Tat-stimulated adhesion of human monocyte-like cells to extracellular matrix proteins
-
Cannabidiol enhances microglial phagocytosis via transient receptor potential (TRP) channel activation
-
The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells
-
Histone modifications are associated with Î9-tetrahydrocannabinol-mediated alterations in antigen-specific T cell responses
-
What we know and do not know about the cannabinoid receptor 2 (CB2)
-
Role of Endocannabinoid Activation of Peripheral CB1 Receptors in the Regulation of Autoimmune Disease
-
Cannabis use by individuals with multiple sclerosis: effects on specific immune parameters
-
Inhaled medicinal cannabis and the immunocompromised patient
-
Therapeutical Potential of CB2 Receptors in Immune-Related Diseases
-
CANNABINOIDS INCREASE LUNG CANCER CELL LYSIS BY LYMPHOKINE-ACTIVATED KILLER CELLS VIA UPREGULATION OF ICAM-1
-
Cannabinoid receptor type 2 activation in atherosclerosis and acute cardiovascular diseases
-
Possible Immunosuppressive Effects of Drug Exposure and Environmental and Nutritional Effects on Infection and Vaccination
-
Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function
-
Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells
-
Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells
-
Endocannabinoid signaling in innate and adaptive immunity
-
Endocannabinoid signaling in innate and adaptive immunity
-
Pathogenesis of Systemic Sclerosis
-
Differential immune mechanism to HIV-1 Tat variants and its regulation by AEA
-
Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis
-
Expression Analysis of CB2-GFP BAC Transgenic Mice
-
Cannabis â the Israeli perspective
-
Restoring homeostasis of CD4(+) T cells in hepatitis-B-virus-related liver fibrosis
-
Crosstalk between endocannabinoid and immune systems: a potential dysregulation in depression?
-
Monoglyceride lipase deficiency modulates endocannabinoid signaling and improves plaque stability in ApoE-knockout mice
-
Alcohol Versus Cannabinoids: A Review of Their Opposite Neuro-Immunomodulatory Effects and Future Therapeutic Potentials
-
Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis
-
Î9 Tetrahydrocannabinol-mediated epigenetic modifications elicit myeloid-derived cell activation via STAT3/S100A8
-
Effects of Cannabinoids on T-cell Function and Resistance to Infection
-
Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoylglycerol and arachidonoyl-ethanolamide, and their metabolites
-
Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo
-
A CB2-Selective Cannabinoid Suppresses T-Cell Activities and Increases Tregs and IL-10
-
Targeting cannabinoid receptor-2 pathway by phenylacetylamide suppresses the proliferation of human myeloma cells through mitotic dysregulation and cytoskeleton disruption
-
Î9-Tetrahydrocannabinol attenuates allogeneic host-versus-graft response and delays skin graft rejection through activation of cannabinoid receptor 1 and induction of myeloid-derived suppressor cells
-
Elevated Levels of Endocannabinoids in Chronic Hepatitis C May Modulate Cellular Immune Response and Hepatic Stellate Cell Activation
-
Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses
-
The herbal-derived honokiol and magnolol enhances immune response to infection with methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant S. aureus (MRSA)
-
The cannabinoid receptor 2 is involved in acute rejection of cardiac allografts
-
For whom the endocannabinoid tolls: Modulation of innate immune function and implications for psychiatric disorders
-
The endocannabinoid system and its therapeutic implications in rheumatoid arthritis
-
Modulation of HIVGP120 Antigen-Specific Immune Responses In Vivo by Î9-Tetrahydrocannabinol
-
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity
-
Downstream effects of endocannabinoid on blood cells: implications for health and disease
-
Pro-inflammatory obesity in aged cannabinoid-2 receptor deficient mice
-
Cannabinoid receptor 1 but not 2 mediates macrophage phagocytosis by G(α)i/o /RhoA/ROCK signaling pathway
-
Endocannabinoids and the Immune System in Health and Disease
-
Neuroprotective Effect Is Driven Through the Upregulation of CB1 Receptor in Experimental Autoimmune Encephalomyelitis
-
Combined effects of HIV and marijuana use on neurocognitive functioning and immune status
-
Dietary Carbohydrates that Modulate the Immune System
-
Behavioral, Metabolic, and Immune Consequences of Chronic Alcohol or Cannabinoids on HIV/AIDs: Studies in the Non-Human Primate SIV Model
-
Lipid signaling in adipose tissue: Connecting inflammation & metabolism
-
Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine neuropathic pain model
-
Up-regulation of immunomodulatory effects of mouse bone-marrow derived mesenchymal stem cells by tetrahydrocannabinol pre-treatment involving cannabinoid receptor CB2
-
Endocannabinoids as Guardians of Metastasis
-
A Randomized Placebo Controlled Trial of Ibuprofen for Respiratory Syncytial Virus Infection in a Bovine Model
-
Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells
-
Acetaminophen Attenuates House Dust Mite Induced Allergic Airway Disease in Mice
-
Interaction between Cannabinoid System and Toll-Like Receptors Controls Inflammation.
-
CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation
-
The CB2 receptor and its role as a regulator of inflammation
-
CB2 receptor activation prevents glial-derived neurotoxic mediator production, BBB leakage and peripheral immune cell infiltration and rescues dopamine neurons in the MPTP model of Parkinsonâs disease
-
Longitudinal examination of the intestinal lamina propria cellular compartment of SIVinfected rhesus macaques provides broader and deeper insights into the link between aberrant microRNA expression and persistent immune activation
-
Effects of Different Levels of Hemp Seed (Cannabis Sativa L.) and Dextran Oligosaccharide on Growth Performance and Antibody Titer Response of Broiler Chickens
-
Synthetic Cannabinoid-Induced Immunosuppression Augments Cerebellar Dysfunction in Tetanus-Toxin Treated Mice
-
Cannabidiol limits Tcell-mediated chronic autoimmune myocarditis: implications to autoimmune disorders and organ transplantation. (click âMolecular Medicineâ for
-
Anti-N-methyl-D-aspartate receptor encephalitis and drug abuse â the probable role of molecular mimicry or the overstimulation of CB receptors in a 17-year-old adolescent â case report
-
Structure of Protein That Guides the Immune System Uncovered
-
The emerging role of the cannabinoid receptor family in peripheral and neuro-immune interactions.
-
Cannabinoids and autoimmune diseases: A systematic review
-
Marijuana-derived Î-9-tetrahydrocannabinol suppresses Th1/Th17 cell-mediated delayed-type hypersensitivity through microRNA regulation
-
Production of endocannabinoids by activated T cells and B cells modulates inflammation associated with delayed type hypersensitivity
-
No significant effect of cannabis use on the count and percentage of circulating CD4 Tcells in HIV-HCV co-infected patients (ANRS CO13-HEPAVIH French cohort)
-
Toll-like receptor signalling as a cannabinoid target in Multiple Sclerosis
-
Chronic Î9-Tetrahydrocannabinol Administration Reduces IgE+B Cells but Unlikely Enhances Pathogenic SIVmac251 Infection in Male Rhesus Macaques of Chinese Origin
-
Expression analysis of cannabinoid receptors 1 and 2 in B cells during pregnancy and their role on cytokine production
-
Endocannabinoid system: a promising therapeutic target for the treatment of haematological malignancies?
-
Ethanol downregulates N-acyl phosphatidylethanolamine-phospholipase D expression in BV2 microglial cells via epigenetic mechanisms
-
Reduced Noradrenergic Signaling in the Spleen Capsule in the Absence of CB1 and CB2 Cannabinoid Receptors
-
Fatty acid amide hydrolase (FAAH) blockade ameliorates experimental colitis by altering microRNA expression and suppressing inflammation
-
Cannabinoids and Neuro-Inflammation: Regulation of Brain Immune Response
-
Microglia activation states and cannabinoid system: Therapeutic implications
-
Experimental Cannabinoid 2 Receptor Inhibition in CNS Injury-Induced Immunodeficiency Syndrome
-
Modulation of monocytes by bioactive lipid anandamide in multiple sclerosis involves distinct Toll-like receptors
-
Anandamide Suppresses Proinflammatory T Cell Responses In Vitro through Type-1 Cannabinoid Receptor-Mediated mTOR Inhibition in Human Keratinocytes
-
Effect of marijuana use on thyroid function and autoimmunity
-
Medical Cannabis â another piece in the mosaic of autoimmunity?
-
Cannabidiol (CBD) induces functional Tregs in response to low-level T cell activation
-
CB2 receptors regulate natural killer cells that limit allergic airway inflammation in a murine model of asthma
-
Identification of an endocannabinoid system in the rat pars tuberalis-a possible interface in the hypothalamic-pituitary-adrenal system?
-
Cannabinoid receptors on peripheral leukocytes from patients with schizophrenia: Evidence for defective immunomodulatory mechanisms
-
Potent immunomodulatory activity of a highly selective cannabinoid CB2 agonist on immune cells from healthy subjects and patients with multiple sclerosis
-
Serum endocannabinoids and N-acyl ethanolamines and the influence of simulated solar UVR exposure in humans in vivo
IMMUNE THROMBOCYTOPENIA (7)
-
Immune thrombocytopenia in children and adults: whatâs the same, whatâs different?
-
CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura
-
Childhood immune thrombocytopenia-who will spontaneously recover?
-
Cannabinoid CB2 receptor gene (CNR2) polymorphism is associated with chronic childhood immune thrombocytopenia in Egypt
-
2-Arachidonoylglycerol enhances platelet formation from human megakaryoblasts
-
Synthetic marijuana âK2â induced ITP
-
Distinctive effects of eicosapentaenoic and docosahexaenoic acids in regulating neural stem cell fate are mediated via endocannabinoid signalling pathways
INDICATIONS AND CLINICAL USES (29)
-
Information for Health Care Professionals- Marihuana (marijuana, cannabis) dried plant for administration by ingestion or other means (Health Canada)
-
âWho Are Medical Marijuana Patients? Population Characteristics from Nine California Assessment Clinicsâ
-
Cannabis and Its Derivatives: Review of Medical Use
-
An Analysis of Applicants Presenting to a Medical Marijuana Specialty Practice in California
-
Medical cannabis: the opportunity versus the temptation
-
Medical Marijuana: Clearing Away the Smoke
-
Therapeutic Potentials and uses of Cannabinoid Agonists in Health and Disease Conditions
-
The Therapeutic Potential of Cannabis and Cannabinoids
-
Marijuana: modern medical chimaera
-
Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators
-
Cannabis Strain Explorer
-
Therapeutic potential of cannabinoid medicines
-
The pharmacologic and clinical effects of medical cannabis
-
Cannabis for therapeutic purposes: Patient characteristics, access, and reasons for use
-
The prevalence and incidence of medicinal cannabis on prescription in The Netherlands
-
Synthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sample
-
Therapeutic benefits of cannabis: a patient survey
-
Medical marijuana: more questions than answers
-
Medical marijuana: more questions than answers
-
The Comprehensive Report on the Cannabis Extract Movement and the Use of Cannabis Extracts to Treat Diseases
-
Report on Medical Cannabis Research, What the Science Says
-
Therapeutic Satisfaction and Subjective Effects of Different Strains of Pharmaceutical-Grade Cannabis
-
(Mo1122) Prevalence and Characterization of Cannabinoid Use in Patients With Gastrointestinal Disorders
-
Discriminating the effects of Cannabis sativa and Cannabis indica: a web survey of medical cannabis users
-
Plant derived substances with anti-cancer activity: from folklore to practice
-
Medical marijuana: review of the science and implications for developmental-behavioral pediatric practice
-
Medicinal cannabis
-
Evidence for Medicinal Use of Cannabis
-
Pros and cons of medical cannabis use by people with chronic brain disorders
INFANTS (46)
-
Use of dronabinol (delta-9-THC) in autism: A prospective single-case-study with an early infantile autistic child
-
The Maternal Lifestyle Study: Sleep Problems in Children with Prenatal Substance Exposure
-
The cannabinoid WIN55212-2 promotes neural repair after neonatal hypoxia-ischemia
-
CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura
-
Examining the Health and Drug Exposures among Canadian Children Residing in Drug-Producing Homes
-
Prolonged coma in a child due to hashish ingestion with quantitation of THC metabolites in urine
-
Unresolved Discrepancies between Cannabinoid Test Results for Infant Urine
-
Acute cannabis poisoning in a 10-month-old infant
-
Cannabinoid modulation of mother-infant interaction: is it just about milk?
-
Unexpected interference of baby wash products with a cannabinoid (THC) immunoassay.
-
The role of child protection in cannabis grow-operations
-
The consequences of pain in early life: injury-induced plasticity in developing pain pathways
-
Meconium Drug Testing in Multiple Births in the USA
-
Contribution of in utero drug exposure when interpreting hair results in young children
-
New horizons for newborn brain protection: enhancing endogenous neuroprotection
-
A cannabinoid-intoxicated child treated with dexmedetomidine: a case report
-
Unintentional Pediatric Exposure to a Synthetic Cannabinoid (AB-PINACA) Resulting in Coma and Intubation
-
Lipid mediator profile in vernix caseosa reflects skin barrier development
-
Perinatal asphyxia results in altered expression of the hippocampal acylethanolamide / endocannabinoid signaling system associated to memory impairments in postweaned rats
-
Prenatal exposure to recreational drugs affects global motion perception in preschool children
-
Long-term consequences of perinatal and adolescent cannabinoid exposure on neural and psychological processes
-
Association between paracetamol use in infancy or childhood with body mass index
-
Use of paracetamol during pregnancy and child neurological development
-
Role of the endocannabinoid system in the mechanisms involved in the LPS-induced preterm labor
-
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
-
Pure cannabidiol in the treatment of malignant migrating partial seizures in infancy: a case report
-
Endocannabinoid Levels in Newborns in Relation to the Mode of Delivery
-
Cannabinoid receptor 2 attenuates microglial accumulation and brain injury following germinal matrix hemorrhage via ERK dephosphorylation in vivo and in vitro
-
Retrospective Analysis of Tetrahydrocannabinol Based on 31 Neurologically Critically Ill Children
-
Maternal marijuana use and neonatal morbidity
-
Pharmacological Preventions of Brain Injury Following Experimental Germinal Matrix Hemorrhage: an Up-to-Date Review
-
Association between marijuana use and adverse obstetrical and neonatal outcomes
-
Marijuana use and pregnancy: prevalence, associated characteristics, and birth outcomes
-
Sudden onset unexplained encephalopathy in infants: think of cannabis intoxication
-
Transient increase of interleukin-1β after prolonged febrile seizures promotes adult epileptogenesis through long-lasting upregulating endocannabinoid signaling
-
Maternal marijuana use has independent effects on risk for spontaneous preterm birth but not other common late pregnancy complications
-
Maternal Caloric Restriction Implemented during the Preconceptional and Pregnancy Period Alters Hypothalamic and Hippocampal Endocannabinoid Levels at Birth and Induces Overweight and Increased Adiposity at Adulthood in Male Rat Offspring
-
Acetaminophen Use for Fever in Children Associated with Autism Spectrum Disorder
-
Detecting biomarkers of secondhand marijuana smoke in young children
-
Nutritional n-3 PUFA Deficiency Abolishes Endocannabinoid Gating of Hippocampal Long-Term Potentiation
-
Marijuana Use and Its Effects in Pregnancy
-
Sexually-dimorphic alterations in cannabinoid receptor density depend upon prenatal/early postnatal history
-
Neuroprotective Effects of Cannabidiol In Hypoxic Ischemic Insult: The Therapeutic Window In Newborn Mice
-
Cannabinoid Receptor 2 Activation Restricts Fibrosis and Alleviates Hydrocephalus after Intraventricular Hemorrhage
-
Evaluating a switch from meconium to umbilical cord tissue for newborn drug testing: A retrospective study at an academic medical center
-
Fetal Syndrome of Endocannabinoid Deficiency (FSECD) In Maternal Obesity
INFLAMMATION (426)
-
Cannabinoid-induced apoptosis in immune cells as a pathway to immuno-suppression
-
Cannabinoids and Viral Infections
-
The endocannabinoid system as a target for the treatment of neurodegenerative disease
-
The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis
-
Regulatory Role of Cannabinoid Receptor 1 in Stress-Induced Excitotoxicity and Neuroinflammation
-
Synthesis of Novel Cannabinoid Ligands and Their Use as Anti-Glioma and Anti-Inflammatory Agents
-
Anti-inflammatory effects of the neurotransmitter agonist Honokiol in a mouse model of allergic asthma
-
N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor
-
Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion
-
Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone (SAB378), a peripherally restricted cannabinoid CB1/CB2 receptor agonist, inhibits gastrointestinal motility but has no effect on experimental colitis in mice
-
European Patent Application EP2044935- A composition containing non-psychotropic cannabinoids for the treatment of inflammatory diseases
-
WIN55212-2 ameliorates atherosclerosis associated with suppression of pro-inflammatory responses in ApoE-knockout mice
-
Beneficial effects of cannabinoids (CB) in a murine model of allergen-induced airway inflammation: Role of CB(1)/CB(2) receptors
-
Levels of endocannabinoids and palmitoylethanolamide and their pharmacological manipulation in chronic granulomatous inflammation in rats
-
Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: an intravital microscopy study
-
Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement
-
Evaluation of the Cyclooxygenase Inhibiting Effects of Six Major Cannabinoids Isolated from Cannabis sativa
-
Gut feelings about the endocannabinoid system
-
Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis
-
Local activation of cannabinoid CB1 receptors in the urinary bladder reduces the inflammation-induced sensitization of bladder afferents
-
Cannabinoid CB2 Receptors Contribute to Upregulation of β-endorphin in Inflamed Skin Tissues by Electroacupuncture
-
Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and cell death
-
Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability
-
The Antinociceptive Effects of JWH-015 in Chronic Inflammatory Pain Are Produced by Nitric Oxide-cGMP-PKG-KATP Pathway Activation Mediated by Opioids
-
Cannabinoid Receptor Type 1 Protects Nigrostriatal Dopaminergic Neurons against MPTP Neurotoxicity by Inhibiting Microglial Activation
-
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes
-
Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Î(9)-tetrahydrocannabinol in BV-2 microglial cells
-
Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress
-
Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death
-
GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils
-
Resolution of inflammation by N-arachidonoylglycine
-
Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ
-
Deletion of cannabinoid receptors 1 and 2 exacerbates APC function to increase inflammation and cellular immunity during influenza infection
-
US Patent 7884133 B2 Cannabidiol derivatives such as 3-(2,6-dihydroxy-4-pentylphenyl)-4-prop-1-en-2-ylcyclohexene-1-carboxylic acid, used as as analgesics, antiinflammatory and antidiarrheal agents
-
Cannabinoids and Innate Immunity: Taking a Toll on Neuroinflammation
-
Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation
-
Immunomodulatory properties of kappa opioids and synthetic cannabinoids in HIV-1 neuropathogenesis
-
A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells
-
The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells
-
Endocannabinoids inhibit release of nerve growth factor by inflammation-activated mast cells
-
Effects of palmitoylethanolamide on release of mast cell peptidases and neurotrophic factors after spinal cord injury
-
Cannabidiol Dampens Streptozotocin-Induced Retinal Inflammation by Targeting of Microglial Activation
-
Prolonged oral Cannabinoid Administration prevents Neuroinflammation, lowers betaamyloid Levels and improves Cognitive Performance in Tg APP 2576 Mice
-
A Dysregulated Endocannabinoid-Eicosanoid Network Supports Pathogenesis in a Mouse Model of Alzheimerâs Disease
-
The fatty acid amide hydrolase inhibitor URB597 exerts anti-inflammatory effects in hippocampus of aged rats and restores an age-related deficit in long-term potentiation
-
Mechanistic and Pharmacological Characterization of PF-04457845: A Highly Potent and Selective Fatty Acid Amide Hydrolase Inhibitor That Reduces Inflammatory and Non-inflammatory Pain
-
The synthetic cannabinoid R(+)WIN55,212-2 augments interferon-β expression via peroxisome proliferator-activated receptor-α
-
Inhibitory effect of 4-O-methylhonokiol on lipopolysaccharide-induced neuro-inflammation, amyloidogenesis and memory impairment via inhibition of nuclear factor-kappaB in vitro and in vivo models
-
N-acyl amines of docosahexaenoic acid and other n-3 polyunsatured fatty acids â From fishy endocannabinoids to potential leads
-
Can the benefits of cannabinoid receptor stimulation on neuroinflammation, neurogenesis and memory during normal aging be useful in AD prevention?
-
Update on the role of cannabinoid receptors after ischemic stroke
-
Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress
-
Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α
-
The fatty acid amide hydrolase inhibitor URB597 exerts anti-inflammatory effects in hippocampus of aged rats and restores an age-related deficit in long-term potentiation
-
Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesions
-
Cannabinoid modulation of neuroinflammatory disorders
-
Targeting Fatty Acid Binding Protein (FABP) Anandamide Transporters â A Novel Strategy for Development of Anti-Inflammatory and Anti-Nociceptive Drugs
-
Fish oil and inflammatory status alter the n-3 to n-6 balance of the endocannabinoid and oxylipin metabolomes in mouse plasma and tissues
-
Review article: The endocannabinoid system in normal and pathological brain ageing
-
Dietary linoleic acid elevates endogenous 2-arachidonoylglycerol and anandamide in Atlantic salmon (Salmo salar L.) and mice and induces weight gain and inflammation in mice
-
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?
-
βâAmyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB1 or CB2 receptors
-
The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice
-
Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: Role for the adenosine A(2A) receptor
-
Differential Modulation by Delta(9)-Tetrahydrocannabinol (â (9)-THC) of CD40 Ligand (CD40L) Expression in Activated Mouse Splenic CD4(+) T cells
-
Methylhonokiol attenuates neuroinflammation: a role for cannabinoid receptors?
-
Activation of Cannabinoid Receptor 2 reduces inflammation in acute experimental pancreatitis via intra-acinar activation of p38 and MK2-dependent mechanisms
-
Cannabidiol (CBD) enhances lipopolysaccharide (LPS)-induced pulmonary inflammation in C57BL/6 mice
-
Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors
-
Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditions
-
Signaling through cannabinoid receptor 2 suppresses murine dendritic cell migration by inhibiting matrix metalloproteinase 9 expression
-
DAGLβ inhibition perturbs a lipid network involved in macrophage inflammatory responses
-
Cannabidiol reduces host immune response and prevents cognitive impairments in Wistar rats submitted to pneumococcal meningitis
-
Mast cell-glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide
-
Endocannabinoids limit excessive mast cell maturation and activation in human skin
-
Differential migratory properties of monocytes isolated from human subjects naïve and non-naïve to Cannabis
-
Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors
-
Pharmacological manipulation of cannabinoid neurotransmission reduces neuroinflammation associated with normal aging
-
Effects of palmitoylethanolamide on intestinal injury and inflammation caused by ischemia-reperfusion in mice
-
4-O-methylhonokiol prevents memory impairment in the Tg2576 transgenic mice model of Alzheimerâs disease via regulation of β-secretase activity
-
The endocannabinoid system: a revolving plate in neuro-immune interaction in health and disease
-
Cannabinoid signalling regulates inflammation and energy balance: The importance of the brain-gut axis
-
The Role of Cannabinoids In Inflammatory Modulation of Allergic Respiratory Disorders, Inflammatory Pain and Ischemic Stroke
-
WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway
-
Cannabinoid receptor-2-selective agonists improve recovery in experimental autoimmune encephalomyelitis
-
Cannabidiol affects the expression of genes involved in zinc homeostasis in BV-2 microglial cells
-
Anti-Inflammatory Effect of the Endocannabinoid Anandamide in Experimental Periodontitis and Stress in the Rat
-
Palmitoylethanolamide reduces early renal dysfunction and injury caused by experimental ischemia and reperfusion in mice
-
Endocannabinoids alleviate proinflammatory conditions by modulating innate immune response in muller glia during inflammation
-
Cannabidiol treatment ameliorates ischemia/reperfusion renal injury in rats
-
A cannabinoid type 2 receptor agonist attenuates blood-brain barrier damage and neurodegeneration in a murine model of traumatic brain injury
-
A Cannabigerol Quinone Alleviates Neuroinflammation in a Chronic Model of Multiple Sclerosis
-
N-arachidonoyl glycine induces macrophage apoptosis via GPR18
-
Anti-Inflammatory Effect of the Endocannabinoid Anandamide in Experimental Periodontitis and Stress in the Rat
-
Metamizol, a non-opioid analgesic, acts via endocannabinoids in the PAG-RVM axis during inflammation in rats
-
CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation
-
Neuroprotective agents: cannabinoids
-
Update on the endocannabinoid-mediated regulation of gelatinase release in arterial wall physiology and atherosclerotic pathophysiology
-
Electroacupuncture reduces the expression of proinflammatory cytokines in inflamed skin tissues through activation of cannabinoid CB2 receptors
-
WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway
-
Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma
-
The cannabinoid receptor type 2 as mediator of mesenchymal stromal cell immuno-suppressive properties
-
The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis
-
Cannabinoid Receptor 2: Potential Role in Immunomodulation and Neuroinflammation
-
Monoacylglycerol Lipase (MAGL) Inhibition Attenuates Acute Lung Injury in Mice
-
The monoacylglycerol lipase inhibitor JZL184 suppresses inflammatory pain in the mouse carrageenan model
-
The cannabinoid CB2 receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain
-
The Dual Effect of Cannabinoid Receptor-1 Deficiency on the Murine Postoperative Ileus
-
Palmitoylethanolamide and luteolin ameliorate development of arthritis caused by injection of collagen type II in mice
-
The Influence of Cannabinoids on Generic Traits of Neurodegeneration
-
A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury
-
Implication of the anti-inflammatory bioactive lipid prostaglandin D2-glycerol ester in the control of macrophage activation and inflammation by ABHD6
-
Selective Activation of Cannabinoid Receptor 2 in Leukocytes Suppresses Their Engagement of the Brain Endothelium and Protects the Blood-Brain Barrier
-
Cannabinoid receptor 2 suppresses leukocyte inflammatory migration by modulating the JNK/c-Jun/Alox5 pathway
-
Cannabinoid 1 Receptors in Keratinocytes Modulate Proinflammatory Chemokine Secretion and Attenuate Contact Allergic Inflammation
-
Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors
-
Inhibition of p38/Mk2 signaling pathway improves the anti-inflammatory effect of WIN55 on mouse experimental colitis
-
Effects on Immune Cells of a New 1,8-Naphthyridin-2-One Derivative and Its Analogues as Selective CB2 Agonists: Implications in Multiple Sclerosis
-
Prospects for cannabinoid therapies in viral encephalitis
-
CB1 Cannabinoid Receptor Agonist Prevents NGF-Induced Sensitization of TRPV1 in Sensory Neurons
-
Anti-inflammatory effects of Cannabinoid 2 Receptor activation in endotoxin-induced uveitis
-
Cannabinoid receptor modulation of the endothelial cell inflammatory response
-
Cytokine release in sepsis
-
Microarray and Pathway Analysis Reveal Distinct Mechanisms Underlying CannabinoidMediated Modulation of LPS-Induced Activation of BV-2 Microglial Cells
-
Reduces Formalin-Induced Neuropathic-Like Behaviour Through Spinal Glial/Microglial Phenotypical Changes in Mice
-
Neuroglial Roots of Neurodegenerative Diseases: Therapeutic Potential of Palmitoyl-ethanolamide in Models of Alzheimerâs Disease
-
New Insights in Mast Cell Modulation by Palmitoylethanolamide
-
The neuroprotective role of endocannabinoids against chemical-induced injury and other adverse effects
-
Inhibition of endocannabinoid degradation in experimental endotoxemia reduces leukocyte adhesion and improves capillary perfusion in the gut
-
Preventive and therapeutic oral administration of the pentacyclic triterpene α,β-amyrin ameliorates dextran sulfate sodium-induced colitis in mice: The relevance of cannabinoid system
-
Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models
-
Endocannabinoids: A unique opportunity to develop multitarget analgesics
-
Endocannabinoids: A unique opportunity to develop multitarget analgesics
-
Glia and Mast Cells as Targets for Palmitoylethanolamide, an Anti-inflammatory and Neuroprotective Lipid Mediator
-
Cannabinoid CB2 receptors as novel target for inhibiting house dust mite induced allergic airway inflammation
-
Amyotrophic Lateral Sclerosis Treatment with Ultramicronized Palmitoylethanolamide: A Case Report
-
3-Carboxamido-5-aryl-isoxazoles as new CB2 agonists for the treatment of colitis
-
CB1 and CB2 contribute to antinociceptive and anti-inflammatory effects of electro-acupuncture on experimental arthritis of the rat temporomandibular joint
-
Cannabinoids Decrease the Th17 Inflammatory Autoimmune Phenotype
-
Controlling 2-arachidonoylglycerol metabolism as an anti-inflammatory strategy
-
Cannabidiol in inflammatory bowel diseases: a brief overview
-
Long-term supplementation of honokiol and magnolol ameliorates body fat accumulation, insulin resistance, and adipose inflammation in high-fat fed mice
-
Anti-inflammatory role of cannabidiol and O-1602 in cerulein-induced acute pancreatitis in mice
-
Magnolol inhibits LPS-induced inflammatory response in uterine epithelial cells : magnolol inhibits LPS-induced inflammatory response
-
Inhibition of fatty acid amide hydrolase (FAAH) as a novel therapeutic strategy in the treatment of pain and inflammatory diseases in the gastrointestinal tract
-
Mitochondrial JNK phosphorylation as a novel therapeutic target to inhibit neuro-inflammation and apoptosis after neonatal ischemic brain damage
-
Endocannabinoids: a unique opportunity to develop multitarget analgesics
-
Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine inflammatory pain model
-
New insights in mast cell modulation by palmitoylethanolamide
-
Palmitoylethanolamide is a new possible pharmacological treatment for the inflammation associated with trauma
-
The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells
-
Anandamide Attenuates Th-17 Cell-Mediated Delayed-Type Hypersensitivity Response by Triggering IL-10 Production and Consequent microRNA Induction
-
Inhibition of Fatty Acid binding proteins elevates brain anandamide levels and produces analgesia
-
A new face of endocannabinoids in pharmacotherapy. Part II. Role of endocannabinoids in inflammation-derived cardiovascular diseases
-
Cannabinoid-induced autophagy regulates suppressor of cytokine signaling (SOCS)-3 in intestinal epithelium
-
CB2 Receptor Activation Ameliorates the Proinflammatory Activity in Acute Lung Injury Induced by Paraquat
-
Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes
-
Activation of GPR40 attenuates chronic inflammation induced impact on pancreatic β-cells health and function
-
Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis
-
Endocannabinoids and inflammatory response in periodontal ligament cells
-
Protective effects of cannabidiol on lesion-induced intervertebral disc degeneration
-
Celastrol Attenuates Inflammatory and Neuropathic Pain Mediated by Cannabinoid Receptor Type 2
-
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
-
Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimerâs disease
-
Tapping into the endocannabinoid system to ameliorate acute inflammatory flares and associated pain in mouse knee joints
-
Cannabinoid receptor type-2 stimulation, blockade, and deletion alters the vascular inflammatory responses to traumatic brain injury
-
Palmitoylethanolamide, a naturally-occurring lipid, is an orally effective intestinal antiinflammatory agent
-
Cannabinoids Alleviate Experimentally Induced Intestinal Inflammation by Acting at Central and Peripheral Receptors
-
Cannabinoid inhibits HIV-1 Tat-stimulated adhesion of human monocyte-like cells to extracellular matrix proteins
-
Peripheral neurobiologic mechanisms of antiallodynic effect of warm water immersion therapy on persistent inflammatory pain
-
Cannabidiol enhances microglial phagocytosis via transient receptor potential (TRP) channel activation
-
Endocannabinoid signalling and the deteriorating brain
-
Chronic administration of Î9-tetrahydrocannabinol induces intestinal anti-inflammatory microRNA expression during acute SIV infection of rhesus macaques
-
The cannabinoid CBâ receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain
-
Systemic Administration of Oleoylethanolamide Protects from Neuroinflammation and Anhedonia Induced by LPS in Rats
-
Cannabinoid type 2 receptor stimulation attenuates brain edema by reducing cerebral leukocyte infiltration following subarachnoid hemorrhage in rats
-
N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon Npalmitoyl-ethanolamine levels and counteracts murine colitis
-
Molecular Basis for the Improvement in Muscle Metaboreflex and Mechanoreflex Control in Exercise-Trained Humans with Chronic Heart Failure
-
Role of Endocannabinoid Activation of Peripheral CB1 Receptors in the Regulation of Autoimmune Disease
-
Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models
-
Treatment with a Heme Oxygenase 1 Inducer Enhances the Antinociceptive Effects of µ-Opioid, δ-Opioid, and Cannabinoid 2 Receptors during Inflammatory Pain
-
Enhanced microglial activity in FAAH-/- animals
-
Cannabis smoking and serum C-reactive protein: A quantile regressions approach based on NHANES 2005â2010
-
In Vitro Anticancer Activity of Plant-Derived Cannabidiol on Prostate Cancer Cell Lines
-
Metabolomics uncovers dietary omega-3 fatty acid-derived metabolites implicated in anti-nociceptive responses after experimental spinal cord injury
-
Cannabinoid receptor activation inhibits cell cycle progression by modulating 14-3-3β
-
The endocannabinoid system: an emerging key player in inflammation
-
Trans-Caryophyllene Suppresses Hypoxia-Induced Neuroinflammatory Responses by Inhibiting NF-κB Activation in Microglia
-
Endocannabinoid 2-Arachidonylglycerol Protects Primary Cultured Neurons Against LPS-Induced Impairments in Rat Caudate Nucleus
-
Endocannabinoids affect innate immunity of Muller glia during HIV-1 Tat cytotoxicity
-
Detailed characterization of the endocannabinoid system in human macrophages and foam cells, and anti-inflammatory role of type-2 cannabinoid receptor
-
Peripheral neurobiologic mechanisms of antiallodynic effect of warm water immersion therapy on persistent inflammatory pain
-
Evaluation of selective cannabinoid CB1 and CB2 receptor agonists in a mouse model of lipopolysaccharide-induced interstitial cystitis
-
Host Neuro- Immuno-Endocrine Responses In Periodontal Disease
-
Role of the Endocannabinoid System in the Neuroendocrine Responses to Inflammation
-
Therapeutical Potential of CB2 Receptors in Immune-Related Diseases
-
Cannabinoid 1 receptors in keratinocytes attenuate FITC-induced mouse atopic-like dermatitis
-
Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands
-
Anti-atherosclerosis role of N-oleoylethanolamine in CB2
-
Endocannabinoid 2-Arachidonylglycerol Protects Primary Cultured Neurons Against Homocysteine-Induced Impairments in Rat Caudate Nucleus Through CB1 Receptor
-
Cannabinoid Receptor-2 and HIV-Associated Neurocognitive Disorders
-
Cannabinoid receptor CB2 prevents development of heart failure in a murine model of pressure overload
-
Ultralow doses of cannabinoid drugs protect the mouse brain from inflammation-induced cognitive damage
-
Increased oxidative stress enhances endocannabinoid tone
-
Cannabis-Based Medicine Reduces Multiple Pathological Processes in AβPP/PS1 Mice
-
Cannabinoid receptor type 2 activation in atherosclerosis and acute cardiovascular diseases
-
Inflammation in diabetic nephropathy: moving toward clinical biomarkers and targets for treatment
-
The differential characterization of GPR55 receptor in human peripheral blood reveals a distinctive expression in monocytes and NK cells and a proinflammatory role in these innate cells
-
Gastric bypass in morbid obese patients is associated with reduction in adipose tissue inflammation via N-oleoylethanolamide (OEA)-mediated pathways
-
Mn-SOD Upregulation by Electroacupuncture Attenuates Ischemic Oxidative Damage via CB1R-Mediated STAT3 Phosphorylation
-
Protective effect of palmitoylethanolamide, a naturally-occurring molecule, in a rat model of cystitis
-
Neuroinflammation as a possible link between cannabinoids and addiction
-
The Activated Endocannabinoid System in Atherosclerosis: Driving Force or Protective Mechanism?
-
Potential applications of marijuana and cannabinoids in medicine
-
COX-2-derived endocannabinoid metabolites as novel inflammatory mediators
-
Palmitoylethanolamide inhibits rMCP-5 expression by regulating MITF activation in rat chronic granulomatous inflammation
-
Protective role of the cannabinoid receptor system in A2E-mediated photo-toxicity to retinal pigment epithelium (RPE) cells in an in-vitro model of age-related macular degeneration (AMD)
-
Cannabis smoking and serum C-reactive protein: A quantile regressions approach based on NHANES 2005â2010
-
NONRETROGRADE ENDOCANNABINOID SIGNALING MODULATES RETINAL GANGLION CELL CALCIUM HOMEOSTASIS THROUGH THE TRPV1 CATION CHANNEL
-
Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-α activation
-
How Smoking Marijuana Might Be The Best Way To Prevent Alzheimerâs Disease
-
The spinal anti-inflammatory mechanism of motor cortex stimulation: cause of success and refractoriness in neuropathic pain?
-
Cannabinoid Receptor CB2 Is Involved in Tetrahydrocannabinol-Induced Anti-Inflammation against Lipopolysaccharide in MG-63 Cells
-
Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo
-
Tonic Modulation of Nociceptive Behavior and Allodynia by Cannabinoid Receptors in Formalin Test in Rats
-
Monoacylglycerol lipase inhibitor JZL184 reduces neuroinflammatory response in APdE9 mice and in adult mouse glial cells
-
Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function
-
Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells
-
Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells
-
New horizons for newborn brain protection: enhancing endogenous neuroprotection
-
Cannabinoid CB2 Receptors in a Mouse Model of Aβ Amyloidosis: Immunohistochemical Analysis and Suitability as a PET Biomarker of Neuroinflammation
-
Anandamide, Acting via CB2 Receptors, Alleviates LPS-Induced Neuroinflammation in Rat Primary Microglial Cultures
-
CB2R orchestrates fibrogenesis through regulation of inflammatory response during the repair of skeletal muscle contusion
-
Time-Dependent Protection of CB2 Receptor Agonist in Stroke
-
Differential immune mechanism to HIV-1 Tat variants and its regulation by AEA
-
High Times for Painful Blues: The Endocannabinoid System in Pain-Depression Comorbidity
-
Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis
-
Expression Analysis of CB2-GFP BAC Transgenic Mice
-
Potential Therapeutical Contributions of the Endocannabinoid System towards Aging and Alzheimerâs Disease
-
Crosstalk between endocannabinoid and immune systems: a potential dysregulation in depression?
-
Monoglyceride lipase deficiency modulates endocannabinoid signaling and improves plaque stability in ApoE-knockout mice
-
GPR55 â a putative âtype 3â cannabinoid receptor in inflammation
-
Oxyradical Stress, Endocannabinoids, and Atherosclerosis
-
Alcohol and Cannabinoids Differentially Affect HIV Infection and Function of Human Monocyte-Derived Dendritic Cells (MDDC)
-
Fever Is Mediated by Conversion of Endocannabinoid 2-Arachidonoylglycerol to Prostaglandin E2
-
Anti-inflammatory effects of N-acylethanolamines in rheumatoid arthritis synovial cells are mediated by TRPV1 and TRPA1 in a COX-2 dependent manner
-
Deletion of Monoglyceride Lipase in Astrocytes Attenuates Lipopolysaccharide-Induced Neuro-inflammation
-
Circulating endocannabinoids during hematopoietic stem cell transplantation: A pilot study
-
Circulating endocannabinoids during hematopoietic stem cell transplantation: A pilot study
-
Dietary DHA reduced downstream endocannabinoid and inflammatory gene expression, epididymal fat mass, and improved aspects of glucose use in muscle in C57BL/6J mice
-
Dietary DHA reduced downstream endocannabinoid and inflammatory gene expression, epididymal fat mass, and improved aspects of glucose use in muscle in C57BL/6J mice
-
HU-446 and HU-465, derivatives of the non-psychoactive cannabinoid cannabidiol, decrease the activation of encephalitogenic T cells
-
Nitric oxide secretion in human conjunctival fibroblasts is inhibited by alpha linolenic acid.
-
4â²-O-methylhonokiol increases levels of 2-arachidonoyl glycerol in mouse brain via selective inhibition of its COX-2-mediated oxygenation.
-
Î9 Tetrahydrocannabinol attenuates Staphylococcal enterotoxin B-induced inflammatory lung injury and prevents mortality in mice by modulation of miR-17-92 cluster and induction of T-regulatory cells
-
Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis
-
Activation of Cannabinoid Type Two Receptors (CB2) Diminish Inflammatory Responses in Macrophages and Brain Endothelium
-
Effects of Cannabinoids on T-cell Function and Resistance to Infection
-
Effects of Cannabinoids on T-cell Function and Resistance to Infection
-
Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoylglycerol and arachidonoyl-ethanolamide, and their metabolites
-
Overcoming the Bell-Shaped Dose-Response of Cannabidiol by Using Cannabis Extract Enriched in Cannabidiol
-
Endogenous 2-Arachidonoylglycerol Alleviates Cyclooxygenases-2 Elevation-Mediated Neuronal Injury from SO2 Inhalation via PPARγ Pathway
-
Fatty acid amide hydrolase inhibitors: a patent review (2009-2014
-
Fatty acid amide hydrolase inhibitors: a patent review (2009- 2014
-
Polyunsaturated fatty acids and inflammation
-
Polyunsaturated fatty acids and inflammation
-
The effect of FAAH, MAGL, and Dual FAAH/MAGL inhibition on inflammatory and colorectal distension-induced visceral pain models in Rodents
-
The effect of FAAH, MAGL, and Dual FAAH/MAGL inhibition on inflammatory and colorectal distension-induced visceral pain models in Rodents
-
Distribution of Bioactive Lipid Mediators in Human Skin
-
Distribution of Bioactive Lipid Mediators in Human Skin.
-
Tonic Modulation of Nociceptive Behavior and Allodynia by Cannabinoid Receptors in Formalin Test in Rats (click Full Text Links for
-
Cannabinoid receptor-specific mechanisms to ameliorate pain in sickle cell anemia via inhibition of mast cell activation and neurogenic inflammation
-
Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids
-
Activation of cannabinoid receptor 2 attenuates synovitis and joint destruction in collagen-induced arthritis
-
Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses
-
Magnolol inhibits the inflammatory response in mouse mammary epithelial cells and a mouse mastitis model
-
Activation of murine microglial N9 cells is attenuated through cannabinoid receptor CB2 signaling
-
Cannabidiol (CBD) and its analogs: a review of their effects on inflammation
-
For whom the endocannabinoid tolls: Modulation of innate immune function and implications for psychiatric disorders
-
The endocannabinoid system and its therapeutic implications in rheumatoid arthritis
-
Minocycline Attenuates Neonatal Germinal-Matrix-Hemorrhage-Induced Neuroinflammation and Brain Edema by Activating Cannabinoid Receptor 2
-
Potential of the cannabinoid CB2 receptor as a pharmacological target against inflammation in Parkinsonâs disease
-
Differential upregulation of the cannabinoid CB2 receptor in neurotoxic and inflammation-driven rat models of Parkinsonâs disease
-
The monoacylglycerol lipase inhibitor JZL184 decreases inflammatory response in skeletal muscle contusion in rats
-
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity
-
The effect of endocannabinoid system in ischemia-reperfusion injury: a friend or a foe?
-
Downstream effects of endocannabinoid on blood cells: implications for health and disease
-
Lipopolysaccharide-induced murine embryonic resorption involves changes in endocannabinoid profiling and alters progesterone secretion and inflammatory response by a CB1-mediated fashion
-
N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution
-
Involvement of cannabinoid receptors in infrasonic noise-induced neuronal impairment
-
Activation of CB2 receptor is required for the therapeutic effect of ABHD6 inhibition in experimental autoimmune encephalomyelitis
-
ical cannabinoid receptor 1 agonist attenuates the cutaneous inflammatory responses in oxazolone-induced atopic dermatitis model
-
Impact of a synthetic cannabinoid (CP-47,497-C8) on protein expression in human cells: evidence for induction of inflammation and DNA damage
-
Novel Triazolopyrimidine-Derived Cannabinoid Receptor 2 Agonists As Potential Treatment for Inflammatory Kidney Diseases
-
Pro-inflammatory obesity in aged cannabinoid-2 receptor deficient mice
-
Fatty acids, endocannabinoids and inflammation
-
Endocannabinoid regulation of amyloid-induced neuroinflammation
-
Lipopolysaccharide Suppresses Carboxylesterase 2g Activity and 2-Arachidonylglycerol Hydrolysis: A Possible Mechanism to Regulate Inflammation
-
Cannabinoid 2 receptor activation reduces leukocyte adhesion and improves capillary perfusionin the iridial microvasculature during systemic inflammation
-
Neuroprotective Effect Is Driven Through the Upregulation of CB1 Receptor in Experimental Autoimmune Encephalomyelitis
-
Deletion of G-protein coupled receptor 55 promotes obesity by reducing physical activity
-
Cannabinoid Receptor Type 2 Agonist Attenuates Acute Neurogenic Pulmonary Edema by Preventing Neutrophil Migration after Subarachnoid Hemorrhage in Rats
-
A Double Whammy: Targeting Both Fatty Acid Amide Hydrolase (FAAH) and Cyclooxygenase (COX) To Treat Pain and Inflammation
-
Î9-Tetrahydrocannabinol (Î9-THC) Promotes Neuroimmune-Modulatory MicroRNA Profile in Striatum of Simian Immunodeficiency Virus (SIV)-Infected Macaques
-
Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase: New Targets for Future Antidepressants
-
Adelmidrol increases the endogenous concentrations of palmitoylethanolamide in canine keratinocytes and down-regulates an inflammatory reaction in an in vitro model of contact allergic dermatitis
-
Endocannabinoids â at the crossroads between the gut microbiota and host metabolism
-
Cell type-specific modulation of lipid mediatorâs formation in murine adipose tissue by omega-3 fatty acids
-
Cannabinoid receptor 2 deficiency results in reduced neuroinflammation in an Alzheimerâs disease mouse model
-
Differential effects of self-reported lifetime marijuana use on interleukin-1 alpha and tumor necrosis factor in African American adults
-
Lipid signaling in adipose tissue: Connecting inflammation & metabolism
-
Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine neuropathic pain model
-
Myeloid-Specific Deletion of Diacylglycerol Lipase α Inhibits Atherogenesis in ApoEDeficient Mice
-
Monoglyceride lipase deficiency modulates endocannabinoid signaling and improves plaque stability in ApoE-knockout mice
-
Characterization of a novel adult murine immortalized microglial cell line and its activation by amyloid-beta
-
Up-regulation of immunomodulatory effects of mouse bone-marrow derived mesenchymal stem cells by tetrahydrocannabinol pre-treatment involving cannabinoid receptor CB2
-
Selective Cannabinoid Receptor-1 Agonists Regulate Mast Cell Activation in an Oxazolone-Induced Atopic Dermatitis Model
-
Vaccenic acid suppresses intestinal inflammation by increasing the endocannabinoid anandamide and non-cannabinoid signaling molecules in a rat model of the metabolic syndrome
-
Differential Regulation of Eicosanoid and Endocannabinoid Production by Inflammatory Mediators in Human Choriodecidua
-
Exogenous hepatitis B virus envelope proteins induce endoplasmic reticulum stress: involvement of cannabinoid axis in liver cancer cells
-
New insights into the yin and yang of the endocannabinoid system in health and disease
-
CB2 cannabinoid receptor is involved in the anti-inflammatory effects of leptin in a model of traumatic brain injury
-
Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing Remitting Multiple Sclerosis
-
Editorial: Lung macrophages high on cannabinoids: jamming PAMs and taming TAMs?
-
Protective Action of Anandamide and its COX-2 Metabolite against L-Homocysteine induced NLRP3 Inflammasome Activation and Injury in Podocytes
-
Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells
-
Gastric acid inhibitory and gastric protective effects of Cannabis and cannabinoids
-
CB2 Cannabinoid Receptor As Potential Target against Alzheimerâs Disease
-
Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids
-
Expression of the endocannabinoid receptors in human fascial tissue
-
The Cannabinoid Receptor 2 Protects Against Alcoholic Liver Disease Via a Macrophage Autophagy-Dependent Pathway
-
The synthetic cannabinoid WIN55,212-2 mesylate decreases the production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts by activating CB2, TRPV1, TRPA1 and yet unidentified receptor targets
-
Immunohistochemical analysis of cannabinoid receptor 1 expression in steatotic rat livers
-
Cannabinoid receptor 2 modulates susceptibility to experimental cerebral malaria through a CCL17-dependent mechanism
-
Spontaneous Cannabinoid Receptor 2 (CB2) Expression in the Cochlea of Adult Albino Rat and Its Up-Regulation after Cisplatin Treatment
-
Interaction between Cannabinoid System and Toll-Like Receptors Controls Inflammation.
-
Turning Down the Thermostat: Modulating the Endocannabinoid System in Ocular Inflammation and Pain
-
Role of Gut Microbiota in the Aetiology of Obesity: Proposed Mechanisms and Review of the Literature
-
Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats
-
The CB2 receptor and its role as a regulator of inflammation
-
Anti-inflammatory effect of cannabinoid agonist WIN55, 212 on mouse experimental colitis is related to inhibition of p38MAPK
-
Effects of Adolescent Intermittent Alcohol Exposure on the Expression of Endocannabinoid Signaling-Related Proteins in the Spleen of Young Adult Rats
-
Mild Traumatic Brain Injury Produces Neuron Loss That Can Be Rescued by Modulating Microglial Activation Using a CB2 Receptor Inverse Agonist
-
Longitudinal examination of the intestinal lamina propria cellular compartment of SIVinfected rhesus macaques provides broader and deeper insights into the link between aberrant microRNA expression and persistent immune activation
-
An Orally Active Cannabis Extract with High Content in Cannabidiol attenuates Chemically-induced Intestinal Inflammation and Hypermotility in the Mouse
-
Activation of Cannabinoid Receptor 2 Ameliorates DSS-Induced Colitis through Inhibiting NLRP3 Inflammasome in Macrophages
-
Target regulation of PI3K/Akt/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis
-
Interaction between Cannabinoid System and Toll-Like Receptors Controls Inflammation
-
Cannabinoid receptor 2 as anti-obesity target: inflammation, fat storage and browning modulation
-
Cannabidiol limits Tcell-mediated chronic autoimmune myocarditis: implications to autoimmune disorders and organ transplantation. (click âMolecular Medicineâ for
-
Getting into the weed: the role of the endocannabinoid system in the brain-gut axis
-
G protein-coupled receptor 18: A potential role for endocannabinoid signalling in metabolic dysfunction
-
Cannabinoid Receptor Type 2 Agonist Attenuates Acute Neurogenic Pulmonary Edema by Preventing Neutrophil Migration after Subarachnoid Hemorrhage in Rats
-
The emerging role of the cannabinoid receptor family in peripheral and neuro-immune interactions
-
β-Caryophyllene, a natural sesquiterpene lactone attenuates hyperglycemia mediated oxidative and inflammatory stress in experimental diabetic rats
-
The Endogenous Cannabinoid Anandamide Increases Human Airway Epithelial Cell Permeability through an Arachidonic Acid Metabolite
-
RGS proteins as targets in the treatment of intestinal inflammation and visceral pain: New insights and future perspectives
-
Endocannabinoids in Cerebrovascular Regulation
-
Anti-Inflammatory and Osteoprotective Effects of Cannabinoid-2 Receptor Agonist Hu- 308 in a Rat Model of Lipopolysaccharide-Induced Periodontitis
-
Cannabinoids for the Treatment of Schizophrenia: An Overview
-
Stimulation of cannabinoid CB1 receptors prevents nerve-mediated airway hyperreactivity in NGF-induced inflammation in mouse airways
-
Role of cannabinoids in gastrointestinal mucosal defense and inflammation
-
Endocannabinoid concentrations in hair are associated with PTSD symptom severity
-
N-acyl ethanolamide and eicosanoid involvement in irritant dermatitis
-
Cannabinoids Occlude the HIV-1 Tat-Induced Decrease in GABAergic Neurotransmission in Prefrontal Cortex Slices
-
Marijuana-derived Î-9-tetrahydrocannabinol suppresses Th1/Th17 cell-mediated delayed-type hypersensitivity through microRNA regulation
-
Production of endocannabinoids by activated T cells and B cells modulates inflammation associated with delayed type hypersensitivity
-
2-pentadecyl-2-oxazoline: identification in coffee, synthesis and activity in a rat model of carrageenan-induced hindpaw inflammation
-
Anandamide and its metabolites: what are their roles in the kidney?
-
Crosstalk between liver antioxidant and the endocannabinoid systems after chronic administration of the FAAH inhibitor, URB597, to hypertensive rats
-
Mustard vesicants alter expression of the endocannabinoid system in mouse skin
-
Endocannabinoid 2-Arachidonoylglycerol Suppresses LPS-Induced Inhibition of A-Type Potassium Channel Currents in Caudate Nucleus Neurons Through CB1 Receptor
-
Expression analysis of cannabinoid receptors 1 and 2 in B cells during pregnancy and their role on cytokine production
-
Cannabis for refractory psoriasis-high hopes for a novel treatment and a literature review
-
Inhibition of Endocannabinoid Degradation Improves Outcomes from Mild Traumatic Brain Injury: A Mechanistic Role for Synaptic Hyperexcitability
-
MEDICAL CANNABIS
-
Anti-inflammatory and antioxidant effects of a combination of cannabidiol and moringin in LPS-stimulated macrophages
-
The effect of cannabinoids on dinitrofluorobenzene-induced experimental asthma in mice
-
Cannabinoid receptor-2 stimulation suppresses neuroinflammation by regulating microglial M1/M2 polarization through the cAMP/PKA pathway in an experimental GMH rat model
-
Pharmacological activation of cannabinoid 2 receptor attenuates inflammation, fibrogenesis, and promotes re-epithelialization during skin wound healing
-
N-Oleoylethanolamine reduces inflammatory cytokines and adhesion molecules in TNF- α-induced human umbilical vein endothelial cells by activating CB2 and PPAR-α
-
Upregulation of the cannabinoid CB2 receptor in environmental and viral inflammationdriven rat models of Parkinsonâs disease
-
Fatty acid amide hydrolase (FAAH) blockade ameliorates experimental colitis by altering microRNA expression and suppressing inflammation
-
Docosahexaenoic acid attenuates in endocannabinoid synthesis in RAW 264.7 macrophages activated with benzo(a)pyrene and lipopolysaccharide
-
Cannabinoids and Neuro-Inflammation: Regulation of Brain Immune Response
-
LINOLEIC ACID AND THE PATHOGENESIS OF OBESITY
-
Microglia activation states and cannabinoid system: Therapeutic implications
-
The cannabinoid 2 receptor agonist β-caryophyllene modulates the inflammatory reaction induced by Mycobacterium bovis BCG by inhibiting neutrophil migration
-
Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling
-
Peripheral interactions between cannabinoid and opioid receptor agonists in a model of inflammatory mechanical hyperalgesia
-
Cannabinoids, inflammation, and fibrosis
-
Expression of the Endocannabinoid Receptor 1 in Human Stroke: An Autoptic Study
-
Heterologous Regulation of the Cannabinoid Type 1 Receptor by Angiotensin II in Astrocytes of Spontaneously Hypertensive Rats
-
The gastrointestinal tract â a central organ of cannabinoid signaling in health and disease
-
Endocannabinoids inhibit neurogenic inflammation in murine joints by a non-canonical cannabinoid receptor mechanism
-
Cannabinoid 2 receptor is a novel anti-inflammatory target in experimental proliferative vitreoretinopathy
-
Oleoylethanolamine and palmitoylethanolamine modulate intestinal permeability in vitro via TRPV1 and PPARα
-
Î9-Tetrahydrocannabinol Reverses TNFα-induced Increase in Airway Epithelial Cell Permeability through CB2 Receptors
-
N-palmitoylethanolamide in the anterior cingulate cortex attenuates inflammatory pain behaviour indirectly via a CB1 receptor-mediated mechanism
-
Docosahexaenoyl Serotonin, an endogenously formed n-3 fatty acid-serotonin conjugate has anti-inflammatory properties by attenuating IL-23âIL-17 signalling in macrophages
-
Anandamide Suppresses Proinflammatory T Cell Responses In Vitro through Type-1 Cannabinoid Receptor-Mediated mTOR Inhibition in Human Keratinocytes
-
Gingival Stromal Cells as an In Vitro Model: Cannabidiol Modulates Genes Linked with Amyotrophic Lateral Sclerosis
-
Activation of Cannabinoid Receptor 2 Attenuates Mechanical Allodynia and Neuroinflammatory Responses in a Chronic Post-Ischemic Pain Model of Complex Regional Pain Syndrome Type I in Rats
-
Palmitoylethanolamide reduces inflammation and itch in a mouse model of contact allergic dermatitis
-
Cannabinoids prevent the amyloid β-induced activation of astroglial hemichannels: A neuroprotective mechanism
-
Therapeutic potential of fatty acid amide hydrolase, monoacylglycerol lipase, and Nacylethanolamine acid amidase inhibitors
-
Experimental cannabidiol treatment reduces early pancreatic inflammation in type 1 diabetes
-
Oxyradical Stress Increases the Biosynthesis of 2-Arachidonoylglycerol: Involvement of NADPH Oxidase
-
Cannabinoids, inflammation, and fibrosis
-
Medical Marijuana: Just the Beginning of a Long, Strange Trip?
-
Cannabinoids in the Management of Musculoskeletal or Rheumatic Diseases
-
Antagonism of cannabinoid receptor 1 attenuates the anti-inflammatory effects of electroacupuncture in a rodent model of migraine
-
The combination of β-caryophyllene, baicalin and catechin synergistically suppresses the proliferation and promotes the death of RAW267.4 macrophages in vitro